We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Information about incidents and outbreaks of Ebola and Marburg, both viral haemorrhagic fevers (VHF).
Background information and advice on coronavirus (COVID-19) for health and care professionals.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
Marburg virus is a Filovirus which, along with Ebola virus, can cause a severe and often fatal viral haemorrhagic fever (VHF).
Information on variants of the SARS-CoV-2 virus.
RVU provides laboratory services for respiratory virus infections including Middle East respiratory syndrome coronavirus (MERS-CoV).
VRD provides clinical advice and laboratory investigations for a wide range of human virus infections.
Clinical advice on West Nile virus including symptoms, diagnosis and epidemiology.
EVU provides diagnostic and reference services for astroviruses, enteroviruses, enteric adenoviruses, noroviruses, rotaviruses and sapoviruses.
Lassa virus causes Lassa fever, an acute viral haemorrhagic fever (VHF).
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Practical advice for clinicians caring for immunocompromised persons who wish to travel or who have travelled to Zika-affected countries or areas.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
The epidemiology, symptoms, diagnosis and management of Nipah virus infections.
Examples of viral haemorrhagic fevers (VHFs) include Lassa fever, Crimean-Congo haemorrhagic fever, Marburg and Ebola virus diseases.
Guillain-Barré syndrome is a rare neurological condition which can occur following Zika virus infection.
Sets out COVID-19 testing for hospice patients and staff.
Travel and clinical advice on Zika: assessing pregnant women following travel; epidemiology; symptoms; transmission.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).